Table 2.

Baseline characteristics of treatment-naïve patients treated with haplo donors

No.	Age and sex	Severity	Clonality PNH MK		Donor	ABO compatibility	CMV status
1	16 M	SAA	+	46 XY	56 M, father	Matched	Matched
2	25 F	vSAA	+	46 XX	13 F, nephew	Matched	Mismatched (donor +)
3	11 F	vSAA	−	46 XX	31 M, father	Minor mismatched	Matched
4	4 F	vSAA	−	46 XX	55 M, father	Matched	Matched
5	25 M	vSAA	−	46 XY	54 M, father	Minor mismatched	Matched
6	22 F	SAA	+	46 XX	54 M, father	Matched	Matched
7	23 F	SAA	+	46 XX	19 M, brother	Matched	Matched
8	17 M*	vSAA	−	46 XY known biallelic MPL	50 F, mother	Matched	Matched
9	17 M	vSAA	+	46 XY	48 M, father	Matched	Matched
10	63 F	vSAA	+	46 XX	34 M, son	Matched	Matched
11	17 M	SAA	+	46 XY	19 M, brother	Matched	Mismatched (donor +)
12	26 M	vSAA	+	46 XY	24 F, cousin	Matched	Matched
13	56 F	vSAA	+	46 XX	29 F, niece	Matched	Mismatched (donor −)
14	51 M	vSAA	+	46 XY	27 F, daughter	Major mismatched	Matched
15	20 M	SAA	−	46 XY	41 F, mother	Matched	Mismatched (donor +)
16	3 F	vSAA	+	46 XX	40 M, father	Matched	Matched
17	52 M	SAA	+	46 XY	44 F, cousin	Matched	Mismatched (donor −)

^*Denotes patient with inherited SAA.